K. Vandormael

发表

Lipid‐altering efficacy of ezetimibe/simvastatin 10/20 mg compared with rosuvastatin 10 mg in high‐risk hypercholesterolaemic patients inadequately controlled with prior statin monotherapy – The IN‐CROSS study

M. Viigimaa, L. Missault, P. Brudi, 2009, International journal of clinical practice.

The Effect of Alendronate on Bone Mass After Distal Forearm Fracture

P. Lips, P. Patka, H. Haarman, 2000, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Multinational, Placebo-Controlled, Randomized Trial of the Effects of Alendronate on Bone Density and Fracture Risk in Postmenopausal Women with Low Bone Mass: Results of the FOSIT Study

D. Felsenberg, H. Pols, D. Hanley, 1999, Osteoporosis International.

Comparison of the effects of intravenous and oral montelukast on airway function: a double blind, placebo controlled, three period, crossover study in asthmatic patients

R. Dockhorn, T. Reiss, J. Leff, 2000, Thorax.

Efficacy of Ezetimibe/Simvastatin 10/40 mg Compared to Doubling the Dose of Low-, Medium- and High-Potency Statin Monotherapy in Patients with a Recent Coronary Event

D. Henry, P. Brudi, T. Pomykaj, 2008, Cardiology.

The Efficacy and Tolerability of Inhaled Montelukast Plus Inhaled Mometasone Compared with Mometasone Alone in Patients with Chronic Asthma

T. Reiss, C. Villarán, S. Smugar, 2011, The Journal of asthma : official journal of the Association for the Care of Asthma.

A Phase I Randomized, Placebo-Controlled, Dose-Exploration Study of Single-Dose Inhaled Montelukast in Patients with Chronic Asthma

T. Reiss, P. Korenblat, Y. Tymofyeyev, 2010, The Journal of asthma : official journal of the Association for the Care of Asthma.

Effect of gaboxadol on patient-reported measures of sleep and waking function in patients with Primary Insomnia: results from two randomized, controlled, 3-month studies.

C. Lines, T. Roth, D. Snavely, 2010, Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine.

A Matching-Adjusted Indirect Comparison of Pembrolizumab + Chemotherapy vs. Nivolumab + Ipilimumab as First-Line Therapies in Patients with PD-L1 TPS ≥1% Metastatic NSCLC

B. Halmos, A. Frederickson, B. Piperdi, 2020, Cancers.

Effect of Rizatriptan and Other Triptans on the Nausea Symptom of Migraine: A Post Hoc Analysis

R. Lipton, C. Lines, P. Goadsby, 2001, Headache.

Indirect comparison of pembrolizumab monotherapy versus nivolumab + ipilimumab in first-line metastatic lung cancer.

B. Halmos, A. Frederickson, B. Piperdi, 2022, Immunotherapy.

Pembrolizumab+chemotherapy versus atezolizumab+chemotherapy+/-bevacizumab for the first-line treatment of non-squamous NSCLC: A matching-adjusted indirect comparison.

B. Halmos, A. Frederickson, B. Piperdi, 2021, Lung cancer.

Alendronate for the treatment of osteoporosis in men.

E. Orwoll, P. Miller, P. Pietschmann, 2000, The New England journal of medicine.

Spontaneous intracranial hypotension causing reversible frontotemporal dementia. Authors' reply

H. Diener, R. Lipton, C. Lines, 2002 .

A comparison of visual analog scale and categorical ratings of headache pain in a randomized controlled clinical trial with migraine patients

C. Lines, W. Malbecq, K. Vandormael, 2001, Pain.

Cost-effectiveness of pembrolizumab in combination with chemotherapy versus chemotherapy and pembrolizumab monotherapy in the first-line treatment of squamous non-small-cell lung cancer in the US

J. Feliciano, D. Vanness, F. Ejzykowicz, 2019, Current medical research and opinion.

Updated Analysis of KEYNOTE-024: Pembrolizumab Versus Platinum-Based Chemotherapy for Advanced Non-Small-Cell Lung Cancer With PD-L1 Tumor Proportion Score of 50% or Greater.

A. Tafreshi, M. Pietanza, M. O'Brien, 2019, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Cost-effectiveness of pembrolizumab in combination with chemotherapy in the 1st line treatment of non-squamous NSCLC in the US

J. Feliciano, D. Vanness, T. Burke, 2018, Journal of medical economics.

Comparison of Rizatriptan 10 mg vs. Naratriptan 2.5 mg in Migraine

N. Legg, K. Vandormael, C. Allen, 1999, European Neurology.

Efficacy and safety of extended‐release niacin/laropiprant plus statin vs. doubling the dose of statin in patients with primary hypercholesterolaemia or mixed dyslipidaemia

J. Paolini, R. Češka, D. Maccubbin, 2010, International journal of clinical practice.

Alendronate prevents loss of bone density associated with discontinuation of hormone replacement therapy: a randomized controlled trial.

B. Stuckey, N. Guañabens, M. Melton, 2003, Archives of internal medicine.

Lipid‐altering efficacy of switching from atorvastatin 10 mg/day to ezetimibe/simvastatin 10/20 mg/day compared to doubling the dose of atorvastatin in hypercholesterolaemic patients with atherosclerosis or coronary heart disease

V. Barrios, N. Amabile, A. Johnson‐Levonas, 2005, International journal of clinical practice.

Lipid‐altering efficacy of ezetimibe/simvastatin 10/40 mg compared with doubling the statin dose in patients admitted to the hospital for a recent coronary event: the INFORCE study

P. Henry, J. Reckless, P. Brudi, 2008, International journal of clinical practice.

Cost-effectiveness of pembrolizumab + chemotherapy versus chemotherapy and pembrolizumab monotherapy in first line treatment of NSCLC in the US – updated analyses with additional trial follow-up

J. Feliciano, K. Vandormael, R. Insinga, 2021, Journal of medical economics.

Comparison of rofecoxib, celecoxib, and naproxen on renal function in elderly subjects receiving a normal‐salt diet

K. Brune, M. Laurenzi, J. Schwartz, 2002, Clinical pharmacology and therapeutics.

PATIENT SATISFACTION WITH RIZATRIPTAN VERSUS OTHER TRIPTANS: DIRECT HEAD‐TO‐HEAD COMPARISONS

Kathleen McCarroll, L. Mannix, K. Vandormael, 2001, International journal of clinical practice.

Comparison of rizatriptan and other triptans on stringent measures of efficacy

R. Lipton, C. Lines, M. Ferrari, 2001, Neurology.

Weekly Oral Alendronic Acid in Male Osteoporosis

T. Schnitzer, E. Orwoll, P. Miller, 2004, Clinical drug investigation.

Tolerability profiles of rofecoxib (Vioxx) and Arthrotec. A comparison of six weeks treatment in patients with osteoarthritis.

D. B. Rodgers, B. Pons-Estel, M. Laurenzi, 2001, Scandinavian journal of rheumatology.

Efficacy of the selective extrasynaptic GABA A agonist, gaboxadol, in a model of transient insomnia: a randomized, controlled clinical trial.

D. Mayleben, S. Deacon, C. Guico-Pabia, 2008, Sleep medicine.

Effect of montelukast for treatment of asthma in cigarette smokers.

Todor A Popov, D. Price, P. Polos, 2013, The Journal of allergy and clinical immunology.

Etoricoxib in the treatment of Korean patients with osteoarthritis in a double-blind, randomized controlled trial

S. Shim, S. Moon, Li Yan, 2014, Current medical research and opinion.

Comparison of the effects of intravenous and oral montelukast on airway function: a double blind, placebo controlled, three period, crossover study in asthmatic patients

R. Baumgartner, M. Noonan, K. Vandormael, 2000, Thorax.